Patient No/sex | Microsatellite markers | ||||||
---|---|---|---|---|---|---|---|
17q D17S250 | 17q THRA1 | 17q D17S855 | 17q D17S579 | 10q D10S109 | 11p HRM | 8q MYC | |
1/F | H | LOH | LOH | H | H | N | H |
2/M | MI | H | H | H | LOH | H | LOH |
3/F | – | H | – | H | H | N | N |
4/M | H | H | – | H | H | H | H |
5/F | H | H | LOH | H | H | N | N |
6/M | H | H | H | LOH | H | LOH | H |
7/M | H | H | H | H | H | N | H |
8/F | LOH | LOH | – | H | N | N | N |
9/F | – | LOH | H | H | H | N | H |
10/F | H | H | LOH | – | H | N | N |
11/M | H | H | – | H | H | H | H |
12/F | H | H | H | H | H | MI | N |
13/F | LOH | LOH | LOH | H | H | H | H |
14/F | H | – | H | H | – | N | H |
15/M | H | H | H | – | H | N | N |
H = heterozygosity; LOH = loss of heterozygosity; MI = microsatellite instability; N = non-informative; — = no data.